Analysis Of Income And Expense [Abstract]

BioInvent International - Filing #702054

Concept 2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
Analysis of income and expense [abstract]
Revenue [abstract]
Revenue
19 384 SEK
147 372 SEK
Material income and expense [abstract]
Research and development expense
258 337 SEK
191 421 SEK
Finance income (cost)
94,000 SEK
859,000 SEK
Other operating income (expense)
470,000 SEK
1 862 SEK
Miscellaneous other operating expense
429,000 SEK
1 132 SEK
Selling, general and administrative expense [abstract]
Selling, general and administrative expense
39 438 SEK
32 155 SEK
Expenses by nature [abstract]
Expenses, by nature
297 734 SEK
222 846 SEK
Comprehensive income, continuing and discontinued operations [abstract]
Comprehensive income
278 444 SEK
278 444 SEK
76 333 SEK
76 333 SEK
Comprehensive income attributable to owners of parent, continuing and discontinued operations [abstract]
Comprehensive income, attributable to owners of parent
278 444 SEK
76 333 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.